RIGL Earnings

Quarterly EPS
$0.71
Q3 2024
$0.81
Q4 2024
$0.64
Q1 2025
$3.33
Q2 2025
$1.55
Q3 2025
$14.72
Q4 2025
$0.47
Q1 2026
$0.93
Q2 2026
Latest Revenue78.7M
Latest Net Income17.3M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.9378.7M17.3M-22.6%-72.1%
Q1 2026$0.4758.8M8.7M+10.3%-26.6%
Q4 2025$14.7269.8M268.1M+21.2%+1,717.3%
Q3 2025$1.5569.5M27.9M+25.6%+118.3%
Q2 2025$3.33101.7M59.6M+176.0%+5,650.0%
Q1 2025$0.6453.3M11.4M+80.6%+236.2%
Q4 2024$0.8157.6M14.3M+60.9%+3,950.0%
Q3 2024$0.7155.3M12.4M+96.6%+315.2%
Q2 2024-$0.0636.8M-1030000
Q1 2024-$0.4729.5M-8247000
Q4 2023$0.0235.8M737.0K
Q3 2023-$0.3328.1M-5692000
Rigel Pharmaceuticals Inc. (New) (RIGL) — Earnings